Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Neoplasms × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 8 Uterine Cervical Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Recurrence 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Carboplatin 271 Cisplatin 203 Radiotherapy 171 Paclitaxel 161 Pemetrexed 152 Docetaxel 142 Gemcitabine 131 pembrolizumab 117 Erlotinib Hydrochloride 90 Etoposide 82 Magnetic Resonance Spectroscopy 80 Bevacizumab 70 Specimen Handling 62 Radiosurgery 62 Nivolumab 60 durvalumab 58 Vinorelbine 48 osimertinib 44 Gefitinib 40 Drug Therapy 39 Topotecan 35 Irinotecan 35 atezolizumab 34 Cyclophosphamide 34 Radiation 32 Biopsy 32 Standard of Care 31 Cetuximab 29 Blood Specimen Collection 26 Immunoglobulin G 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00801736 2013-12-10

ET

University College, London

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡